Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT05793177 (MONSS) for Stroke, Acute, Behavior, Physical Inactivity, Sedentary Behavior is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One trial matched filter criteria
Card View
MONitoring Sedentary Behavior and Light Physical Activity in Patients With Stroke (MONSS)
Clinical Trial NCT05793177 (MONSS) is an interventional study for Stroke, Acute, Behavior, Physical Inactivity, Sedentary Behavior that is recruiting. It started on October 1, 2023 with plans to enroll 100 participants. Led by Zealand University Hospital, it is expected to complete by December 31, 2024. The latest data from ClinicalTrials.gov was last updated on July 25, 2024.
Brief Summary
This randomized control trial (RCT) aims to test the effect of a 12 weeks tailored behavioral intervention on stroke survivors living in the community and compare the results to a control group of stroke survivors participating in standard care. The intervention's purpose is to lower the time spend with sedentary behavior and raise the level of physical activity in stroke survivors throughout their everyday life. The intervention contains two motivational interviews with a focus on goal setting, action planning, motivation, fatigue management, and general information on life after stroke. The primary outcome for behavior change is objectively measured physical activity using an activity tracker (ActivPal4 Micro) and secondary glycohemoglobin and changes in quality of life.
Official Title
Monitoring Sedentary Behavior and Light Physical Activity in Patients With Stroke
Conditions
Stroke, AcuteBehaviorPhysical InactivitySedentary BehaviorPublications
Scientific articles and research papers published about this clinical trial:Other Study IDs
- MONSS
NCT ID Number
Start Date (Actual)
2023-10-01
Last Update Posted
2024-07-25
Completion Date (Estimated)
2024-12-31
Enrollment (Estimated)
100
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Primary Purpose
Prevention
Design Allocation
Randomized
Interventional Model
Single Group
Masking
Single
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
ExperimentalIntervention | Everyday Life is Rehabilitation Behavior change intervention focuses on implementing more movement into everyday life using action planning, goal setting, and fatigue management. |
No InterventionControl | N/A |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Sedentary time | Time participants spend with sedentary behavior compared between the intervention and control group | 12 weeks follow-up |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Physical activity scale (PAS2) | Subjective physical activity | Baseline,12 and 26 weeks follow-up |
The Stroke Specific Quality of Life Scale (SS-QOL) | Quality of life | Baseline,12 and 26 weeks follow-up |
The General Self-efficacy Scale (GSES) | self-efficacy | Baseline,12 and 26 weeks follow-up |
The Multi-dimensional Fatigue Inventory (MFI-20) questionnaire | Fatigue | Baseline,12 and 26 weeks follow-up |
Patient health questionnaire (PHQ-9) | Depression symptoms | Baseline,12 and 26 weeks follow-up |
The Fugl Meyer Assessment (FMA) | The function of upper and lower extremity | Baseline,12 and 26 weeks follow-up |
Timed Up & Go (TUG) test | Mobility | Baseline,12 and 26 weeks follow-up |
Montreal Cognitive Assessment (MoCA) | cognitive assessment | Baseline |
Glycated hemoglobin (HbA1c) | Glycated hemoglobin (HbA1c) | Baseline,6,12 and 26 weeks follow-up |
Eligibility Criteria
Eligible Ages
Child, Adult, Older Adult
Eligible Sexes
All
- Verified ischemic stroke or intracerebral hemorrhage
- Modified rankin score (mRS) 1-3 at discharge
- Discharged with at rehabilitation plan within 1-14 hospitalization days
- Able to ambulate independently
- Speak and understand Danish
- Aphasia
- Unable to give informed consent
- Unable to ambulate independently
- Mental illness
- Other co-morbidity like terminal cancer.
Study Responsible Party
Stefan Sjørslev Bodilsen, Principal Investigator, Ph.d. student, MSPT, PT, Zealand University Hospital
Study Central Contact
Contact: Stefan S Bodilsen, MSPT, +4528401595, [email protected]
1 Study Locations in 1 Countries
Zealand University hospital, Roskilde, 4000, Denmark
Stefan S Bodilsen, Contact, +4528401595, [email protected]
Recruiting